US readies new pharmaceutical tariffs
Levies of 100% on certain medicines would implement threats Trump made last year
Levies of 100% on certain medicines would implement threats Trump made last year
Discussions will include American and international insurance watchdogs
‘He broke a tooth biting the heads off chocolate bunnies’
President says conflict is ‘nearing completion’ but also threatens sweeping new round of strikes
From John W Mullins, Associate Professor of Management Practice, Marketing and Entrepreneurship, London Business School, London NW1, UK
From Sam Ingham, Senior Solicitor, Laura Devine Immigration, London EC4, UK
From Joe Keaney, Retired Librarian, Manchester, UK
From Rosemary McCollin, Executive Vice-President, Fund Solutions (EU & ME), Vistra, London SW1, UK
From Peter Harvey, Bingley, West Yorkshire, UK
Artemis II overcomes technical delays to launch smoothly from Kennedy Space Center
Co-chief appointed to quell dispute quietly resigned last month citing ‘ongoing governance challenges’
As fuel prices rise and the outlook becomes more uncertain, the economics of car choices and manufacturing become harder to ignore
Proportion who are actively posting, sharing or commenting has dropped since last year
Ecommerce giant is trying to catch up with SpaceX’s low Earth orbit internet service
Police arrest three men in possible connection with new Iranian group Ashab al-Yamin
Also in today’s newsletter: SpaceX kicks off largest IPO process in history, and Saudi Arabia bridles at Trump’s handling of Iran war
Confidential submission to US regulator sets up summer listing
Gulf state imposes restrictions after facing attacks from Islamic republic
World’s third-largest supplier hopes Asia trade will offer leverage for much-needed fuel and diesel supplies
Nearly five weeks after US and Israel attacked Iran, Washington’s Gulf ally frets about the damage
Sportswear group’s softer than anticipated outlook stirs concerns about multiyear turnaround plan
Indra’s Ángel Escribano to step down after planned tie-up of EM&E was abandoned following conflict of interest concerns
New drug Foundayo sets up battle with Novo Nordisk for oral obesity drugs